Efficacy and safety of tumor necrosis factor-α inhibitors and mesenchymal stem cells in the treatment of fistulizing Crohn’s disease: a systematic review and network meta-analysis
BackgroundTumor necrosis factor-α inhibitors (anti-TNF-α) and mesenchymal stem cells (MSCs) have been proven to be effective for Perianal fistulizing Crohn’s disease (PFCD). However, no head-to-head clinical trials have directly comparing these two the…